In general, although most authors agree that CK19 reactivity is more frequent, diffuse and strong in papillary carcinoma, its reactivity in follicular neoplasms may limit its utility as a diagnostic marker [22]. Here, KRT19 is linked to thyroid gland papillary carcinoma.